nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—NAT2—prostate cancer	0.196	0.463	CbGaD
Isoniazid—CYP2A6—prostate cancer	0.0795	0.188	CbGaD
Isoniazid—CYP2E1—prostate cancer	0.0564	0.133	CbGaD
Isoniazid—CYP2C19—prostate cancer	0.0559	0.132	CbGaD
Isoniazid—CYP3A4—prostate cancer	0.0355	0.0839	CbGaD
Isoniazid—CYP2C8—Nilutamide—prostate cancer	0.0219	0.058	CbGbCtD
Isoniazid—CYP2C19—Bicalutamide—prostate cancer	0.0184	0.0486	CbGbCtD
Isoniazid—CYP2C19—Nilutamide—prostate cancer	0.0184	0.0486	CbGbCtD
Isoniazid—CYP2C8—Abiraterone—prostate cancer	0.0182	0.048	CbGbCtD
Isoniazid—CYP2E1—Estrone—prostate cancer	0.0176	0.0465	CbGbCtD
Isoniazid—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0169	0.0448	CbGbCtD
Isoniazid—CYP2C9—Bicalutamide—prostate cancer	0.0153	0.0404	CbGbCtD
Isoniazid—CYP2C9—Nilutamide—prostate cancer	0.0153	0.0404	CbGbCtD
Isoniazid—CYP2C19—Flutamide—prostate cancer	0.0153	0.0403	CbGbCtD
Isoniazid—CYP1A2—Flutamide—prostate cancer	0.0141	0.0372	CbGbCtD
Isoniazid—CYP2D6—Bicalutamide—prostate cancer	0.014	0.037	CbGbCtD
Isoniazid—CYP2C8—Cabazitaxel—prostate cancer	0.0135	0.0355	CbGbCtD
Isoniazid—CYP2C8—Ethinyl Estradiol—prostate cancer	0.0117	0.031	CbGbCtD
Isoniazid—CYP2D6—Abiraterone—prostate cancer	0.0116	0.0306	CbGbCtD
Isoniazid—NAT2—urine—prostate cancer	0.0107	0.366	CbGeAlD
Isoniazid—CYP2E1—Mitoxantrone—prostate cancer	0.0105	0.0276	CbGbCtD
Isoniazid—CYP1A2—Estrone—prostate cancer	0.0102	0.0269	CbGbCtD
Isoniazid—CYP2C9—Estrone—prostate cancer	0.00917	0.0242	CbGbCtD
Isoniazid—CYP3A4—Bicalutamide—prostate cancer	0.0089	0.0235	CbGbCtD
Isoniazid—CYP3A4—Estramustine—prostate cancer	0.00828	0.0219	CbGbCtD
Isoniazid—CYP2C8—Estradiol—prostate cancer	0.00755	0.02	CbGbCtD
Isoniazid—CYP3A4—Flutamide—prostate cancer	0.00738	0.0195	CbGbCtD
Isoniazid—CYP3A4—Abiraterone—prostate cancer	0.00738	0.0195	CbGbCtD
Isoniazid—CYP2C9—Capecitabine—prostate cancer	0.00695	0.0184	CbGbCtD
Isoniazid—CYP1A2—Conjugated Estrogens—prostate cancer	0.00666	0.0176	CbGbCtD
Isoniazid—CYP2E1—Etoposide—prostate cancer	0.0066	0.0174	CbGbCtD
Isoniazid—CYP2C19—Estradiol—prostate cancer	0.00634	0.0167	CbGbCtD
Isoniazid—CYP1A2—Estradiol—prostate cancer	0.00585	0.0154	CbGbCtD
Isoniazid—CYP3A4—Cabazitaxel—prostate cancer	0.00546	0.0144	CbGbCtD
Isoniazid—CYP2C19—Prednisone—prostate cancer	0.00545	0.0144	CbGbCtD
Isoniazid—CYP3A4—Estrone—prostate cancer	0.00533	0.0141	CbGbCtD
Isoniazid—CYP2C9—Estradiol—prostate cancer	0.00527	0.0139	CbGbCtD
Isoniazid—CYP2C8—Etoposide—prostate cancer	0.00493	0.013	CbGbCtD
Isoniazid—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00475	0.0126	CbGbCtD
Isoniazid—CYP1A2—Etoposide—prostate cancer	0.00382	0.0101	CbGbCtD
Isoniazid—CYP3A4—Conjugated Estrogens—prostate cancer	0.00349	0.00922	CbGbCtD
Isoniazid—CYP3A4—Mitoxantrone—prostate cancer	0.00317	0.00838	CbGbCtD
Isoniazid—CYP3A4—Estradiol—prostate cancer	0.00306	0.00809	CbGbCtD
Isoniazid—CYP3A4—Prednisone—prostate cancer	0.00263	0.00696	CbGbCtD
Isoniazid—NAT2—renal system—prostate cancer	0.00263	0.0895	CbGeAlD
Isoniazid—CYP2C19—urine—prostate cancer	0.00215	0.0734	CbGeAlD
Isoniazid—CYP2D6—Doxorubicin—prostate cancer	0.00215	0.00567	CbGbCtD
Isoniazid—CYP3A4—Etoposide—prostate cancer	0.002	0.00528	CbGbCtD
Isoniazid—CYP3A4—Docetaxel—prostate cancer	0.00183	0.00483	CbGbCtD
Isoniazid—CYP1A2—urine—prostate cancer	0.00176	0.06	CbGeAlD
Isoniazid—CYP2C9—urine—prostate cancer	0.00167	0.0569	CbGeAlD
Isoniazid—CYP2E1—urine—prostate cancer	0.00158	0.0539	CbGeAlD
Isoniazid—CYP3A4—Doxorubicin—prostate cancer	0.00136	0.0036	CbGbCtD
Isoniazid—CYP3A4—urine—prostate cancer	0.00127	0.0434	CbGeAlD
Isoniazid—CYP2D6—urine—prostate cancer	0.00125	0.0427	CbGeAlD
Isoniazid—CYP2A6—prostate gland—prostate cancer	0.0012	0.041	CbGeAlD
Isoniazid—CYP2A6—seminal vesicle—prostate cancer	0.00102	0.0347	CbGeAlD
Isoniazid—CYP2E1—prostate gland—prostate cancer	0.000568	0.0194	CbGeAlD
Isoniazid—CYP2E1—seminal vesicle—prostate cancer	0.00048	0.0164	CbGeAlD
Isoniazid—CYP2C8—renal system—prostate cancer	0.00046	0.0157	CbGeAlD
Isoniazid—CYP1A2—renal system—prostate cancer	0.00043	0.0147	CbGeAlD
Isoniazid—CYP2E1—renal system—prostate cancer	0.000387	0.0132	CbGeAlD
Isoniazid—CYP2E1—urethra—prostate cancer	0.00038	0.013	CbGeAlD
Isoniazid—CYP3A4—renal system—prostate cancer	0.000311	0.0106	CbGeAlD
Isoniazid—CYP2D6—renal system—prostate cancer	0.000306	0.0104	CbGeAlD
Isoniazid—CYP2C8—testis—prostate cancer	0.000297	0.0101	CbGeAlD
Isoniazid—CYP2E1—testis—prostate cancer	0.00025	0.00853	CbGeAlD
Isoniazid—CYP2D6—testis—prostate cancer	0.000198	0.00675	CbGeAlD
Isoniazid—Hyperglycaemia—Estradiol—prostate cancer	0.000196	0.00272	CcSEcCtD
Isoniazid—Rash—Nilutamide—prostate cancer	0.000196	0.00271	CcSEcCtD
Isoniazid—Discomfort—Ethinyl Estradiol—prostate cancer	0.000196	0.00271	CcSEcCtD
Isoniazid—Rash—Flutamide—prostate cancer	0.000195	0.0027	CcSEcCtD
Isoniazid—Decreased appetite—Bicalutamide—prostate cancer	0.000195	0.0027	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000194	0.00268	CcSEcCtD
Isoniazid—Fatigue—Bicalutamide—prostate cancer	0.000194	0.00268	CcSEcCtD
Isoniazid—Hypersensitivity—Cabazitaxel—prostate cancer	0.000193	0.00267	CcSEcCtD
Isoniazid—Neuropathy peripheral—Estradiol—prostate cancer	0.00019	0.00263	CcSEcCtD
Isoniazid—Jaundice—Estradiol—prostate cancer	0.000189	0.00262	CcSEcCtD
Isoniazid—Asthenia—Cabazitaxel—prostate cancer	0.000188	0.0026	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—prostate cancer	0.000187	0.00259	CcSEcCtD
Isoniazid—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000186	0.00257	CcSEcCtD
Isoniazid—Feeling abnormal—Bicalutamide—prostate cancer	0.000185	0.00256	CcSEcCtD
Isoniazid—Nausea—Nilutamide—prostate cancer	0.000185	0.00256	CcSEcCtD
Isoniazid—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000184	0.00255	CcSEcCtD
Isoniazid—Nausea—Flutamide—prostate cancer	0.000184	0.00255	CcSEcCtD
Isoniazid—Hyperglycaemia—Mitoxantrone—prostate cancer	0.000183	0.00253	CcSEcCtD
Isoniazid—Diabetes mellitus—Capecitabine—prostate cancer	0.000181	0.0025	CcSEcCtD
Isoniazid—Hepatic function abnormal—Capecitabine—prostate cancer	0.00018	0.00249	CcSEcCtD
Isoniazid—Liver injury—Epirubicin—prostate cancer	0.000179	0.00248	CcSEcCtD
Isoniazid—Ill-defined disorder—Goserelin—prostate cancer	0.000178	0.00246	CcSEcCtD
Isoniazid—Body temperature increased—Bicalutamide—prostate cancer	0.000178	0.00246	CcSEcCtD
Isoniazid—Vomiting—Degarelix—prostate cancer	0.000177	0.00245	CcSEcCtD
Isoniazid—Jaundice—Mitoxantrone—prostate cancer	0.000176	0.00244	CcSEcCtD
Isoniazid—Rash—Degarelix—prostate cancer	0.000175	0.00242	CcSEcCtD
Isoniazid—Hepatitis—Estradiol—prostate cancer	0.000174	0.00241	CcSEcCtD
Isoniazid—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000174	0.0024	CcSEcCtD
Isoniazid—Malaise—Goserelin—prostate cancer	0.000173	0.00239	CcSEcCtD
Isoniazid—Agranulocytosis—Mitoxantrone—prostate cancer	0.000169	0.00234	CcSEcCtD
Isoniazid—Vomiting—Cabazitaxel—prostate cancer	0.000166	0.0023	CcSEcCtD
Isoniazid—Convulsion—Goserelin—prostate cancer	0.000166	0.0023	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Epirubicin—prostate cancer	0.000166	0.0023	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—prostate cancer	0.000166	0.00229	CcSEcCtD
Isoniazid—Hypersensitivity—Bicalutamide—prostate cancer	0.000165	0.00229	CcSEcCtD
Isoniazid—Nausea—Degarelix—prostate cancer	0.000165	0.00228	CcSEcCtD
Isoniazid—Convulsion—Conjugated Estrogens—prostate cancer	0.000164	0.00227	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	0.000164	0.00227	CcSEcCtD
Isoniazid—Fatigue—Ethinyl Estradiol—prostate cancer	0.000164	0.00226	CcSEcCtD
Isoniazid—Hepatitis—Mitoxantrone—prostate cancer	0.000162	0.00225	CcSEcCtD
Isoniazid—Asthenia—Bicalutamide—prostate cancer	0.000161	0.00223	CcSEcCtD
Isoniazid—Discomfort—Goserelin—prostate cancer	0.000161	0.00223	CcSEcCtD
Isoniazid—Diabetes mellitus—Prednisone—prostate cancer	0.000161	0.00223	CcSEcCtD
Isoniazid—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000156	0.00216	CcSEcCtD
Isoniazid—Nausea—Cabazitaxel—prostate cancer	0.000156	0.00215	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—prostate cancer	0.000153	0.00212	CcSEcCtD
Isoniazid—Thrombocytopenia—Goserelin—prostate cancer	0.000153	0.00212	CcSEcCtD
Isoniazid—Hepatocellular injury—Epirubicin—prostate cancer	0.000151	0.00209	CcSEcCtD
Isoniazid—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.00015	0.00208	CcSEcCtD
Isoniazid—Anorexia—Goserelin—prostate cancer	0.000149	0.00206	CcSEcCtD
Isoniazid—Neuropathy peripheral—Etoposide—prostate cancer	0.000148	0.00204	CcSEcCtD
Isoniazid—Anorexia—Conjugated Estrogens—prostate cancer	0.000148	0.00204	CcSEcCtD
Isoniazid—Jaundice—Etoposide—prostate cancer	0.000147	0.00203	CcSEcCtD
Isoniazid—Vomiting—Bicalutamide—prostate cancer	0.000143	0.00198	CcSEcCtD
Isoniazid—Rash—Bicalutamide—prostate cancer	0.000142	0.00196	CcSEcCtD
Isoniazid—Aplastic anaemia—Epirubicin—prostate cancer	0.000142	0.00196	CcSEcCtD
Isoniazid—Ill-defined disorder—Estradiol—prostate cancer	0.000141	0.00195	CcSEcCtD
Isoniazid—Agranulocytosis—Etoposide—prostate cancer	0.00014	0.00194	CcSEcCtD
Isoniazid—Paraesthesia—Goserelin—prostate cancer	0.00014	0.00194	CcSEcCtD
Isoniazid—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00014	0.00194	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—prostate cancer	0.00014	0.00193	CcSEcCtD
Isoniazid—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000139	0.00192	CcSEcCtD
Isoniazid—Dyspepsia—Goserelin—prostate cancer	0.000138	0.0019	CcSEcCtD
Isoniazid—Malaise—Estradiol—prostate cancer	0.000137	0.00189	CcSEcCtD
Isoniazid—Psychotic disorder—Prednisone—prostate cancer	0.000137	0.00189	CcSEcCtD
Isoniazid—Dyspepsia—Conjugated Estrogens—prostate cancer	0.000136	0.00189	CcSEcCtD
Isoniazid—Asthenia—Ethinyl Estradiol—prostate cancer	0.000136	0.00188	CcSEcCtD
Isoniazid—Decreased appetite—Goserelin—prostate cancer	0.000136	0.00188	CcSEcCtD
Isoniazid—Fatigue—Goserelin—prostate cancer	0.000135	0.00186	CcSEcCtD
Isoniazid—Decreased appetite—Conjugated Estrogens—prostate cancer	0.000135	0.00186	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000134	0.00185	CcSEcCtD
Isoniazid—Fatigue—Conjugated Estrogens—prostate cancer	0.000133	0.00185	CcSEcCtD
Isoniazid—Nausea—Bicalutamide—prostate cancer	0.000133	0.00185	CcSEcCtD
Isoniazid—Ill-defined disorder—Mitoxantrone—prostate cancer	0.000131	0.00182	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—prostate cancer	0.000131	0.00181	CcSEcCtD
Isoniazid—Feeling abnormal—Goserelin—prostate cancer	0.000129	0.00178	CcSEcCtD
Isoniazid—Lymphadenopathy—Epirubicin—prostate cancer	0.000128	0.00178	CcSEcCtD
Isoniazid—Discomfort—Estradiol—prostate cancer	0.000128	0.00177	CcSEcCtD
Isoniazid—Malaise—Mitoxantrone—prostate cancer	0.000128	0.00176	CcSEcCtD
Isoniazid—Diabetes mellitus—Epirubicin—prostate cancer	0.000126	0.00174	CcSEcCtD
Isoniazid—Hepatic function abnormal—Epirubicin—prostate cancer	0.000125	0.00173	CcSEcCtD
Isoniazid—Body temperature increased—Goserelin—prostate cancer	0.000124	0.00171	CcSEcCtD
Isoniazid—Neuropathy peripheral—Docetaxel—prostate cancer	0.000123	0.0017	CcSEcCtD
Isoniazid—Hyperglycaemia—Capecitabine—prostate cancer	0.000123	0.0017	CcSEcCtD
Isoniazid—Convulsion—Mitoxantrone—prostate cancer	0.000123	0.0017	CcSEcCtD
Isoniazid—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000122	0.00169	CcSEcCtD
Isoniazid—Jaundice—Docetaxel—prostate cancer	0.000122	0.00169	CcSEcCtD
Isoniazid—Vomiting—Ethinyl Estradiol—prostate cancer	0.000121	0.00167	CcSEcCtD
Isoniazid—Rash—Ethinyl Estradiol—prostate cancer	0.00012	0.00166	CcSEcCtD
Isoniazid—Discomfort—Mitoxantrone—prostate cancer	0.000119	0.00165	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—prostate cancer	0.000119	0.00164	CcSEcCtD
Isoniazid—Neuropathy peripheral—Capecitabine—prostate cancer	0.000119	0.00164	CcSEcCtD
Isoniazid—Jaundice—Capecitabine—prostate cancer	0.000118	0.00163	CcSEcCtD
Isoniazid—Agranulocytosis—Docetaxel—prostate cancer	0.000117	0.00162	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—prostate cancer	0.000116	0.00161	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—prostate cancer	0.000116	0.0016	CcSEcCtD
Isoniazid—Hypersensitivity—Goserelin—prostate cancer	0.000115	0.00159	CcSEcCtD
Isoniazid—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000114	0.00158	CcSEcCtD
Isoniazid—Agranulocytosis—Capecitabine—prostate cancer	0.000113	0.00156	CcSEcCtD
Isoniazid—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000113	0.00156	CcSEcCtD
Isoniazid—Nausea—Ethinyl Estradiol—prostate cancer	0.000113	0.00156	CcSEcCtD
Isoniazid—Hepatitis—Docetaxel—prostate cancer	0.000112	0.00155	CcSEcCtD
Isoniazid—Asthenia—Goserelin—prostate cancer	0.000112	0.00155	CcSEcCtD
Isoniazid—Paraesthesia—Estradiol—prostate cancer	0.000111	0.00154	CcSEcCtD
Isoniazid—Asthenia—Conjugated Estrogens—prostate cancer	0.000111	0.00154	CcSEcCtD
Isoniazid—Anorexia—Mitoxantrone—prostate cancer	0.00011	0.00152	CcSEcCtD
Isoniazid—Hyperglycaemia—Prednisone—prostate cancer	0.000109	0.00151	CcSEcCtD
Isoniazid—Ill-defined disorder—Etoposide—prostate cancer	0.000109	0.00151	CcSEcCtD
Isoniazid—Dyspepsia—Estradiol—prostate cancer	0.000109	0.00151	CcSEcCtD
Isoniazid—Hepatitis—Capecitabine—prostate cancer	0.000109	0.0015	CcSEcCtD
Isoniazid—Decreased appetite—Estradiol—prostate cancer	0.000108	0.00149	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Estradiol—prostate cancer	0.000107	0.00148	CcSEcCtD
Isoniazid—Fatigue—Estradiol—prostate cancer	0.000107	0.00148	CcSEcCtD
Isoniazid—Malaise—Etoposide—prostate cancer	0.000106	0.00147	CcSEcCtD
Isoniazid—Neuropathy peripheral—Prednisone—prostate cancer	0.000106	0.00146	CcSEcCtD
Isoniazid—Paraesthesia—Mitoxantrone—prostate cancer	0.000104	0.00143	CcSEcCtD
Isoniazid—Feeling abnormal—Estradiol—prostate cancer	0.000102	0.00141	CcSEcCtD
Isoniazid—Convulsion—Etoposide—prostate cancer	0.000102	0.00141	CcSEcCtD
Isoniazid—Dyspepsia—Mitoxantrone—prostate cancer	0.000102	0.00141	CcSEcCtD
Isoniazid—Decreased appetite—Mitoxantrone—prostate cancer	0.0001	0.00139	CcSEcCtD
Isoniazid—Fatigue—Mitoxantrone—prostate cancer	9.95e-05	0.00138	CcSEcCtD
Isoniazid—Vomiting—Goserelin—prostate cancer	9.93e-05	0.00137	CcSEcCtD
Isoniazid—Discomfort—Etoposide—prostate cancer	9.89e-05	0.00137	CcSEcCtD
Isoniazid—Rash—Goserelin—prostate cancer	9.85e-05	0.00136	CcSEcCtD
Isoniazid—Vomiting—Conjugated Estrogens—prostate cancer	9.84e-05	0.00136	CcSEcCtD
Isoniazid—Body temperature increased—Estradiol—prostate cancer	9.79e-05	0.00135	CcSEcCtD
Isoniazid—Rash—Conjugated Estrogens—prostate cancer	9.76e-05	0.00135	CcSEcCtD
Isoniazid—Feeling abnormal—Mitoxantrone—prostate cancer	9.51e-05	0.00132	CcSEcCtD
Isoniazid—Thrombocytopenia—Etoposide—prostate cancer	9.4e-05	0.0013	CcSEcCtD
Isoniazid—Eosinophilia—Epirubicin—prostate cancer	9.37e-05	0.0013	CcSEcCtD
Isoniazid—Nausea—Goserelin—prostate cancer	9.28e-05	0.00128	CcSEcCtD
Isoniazid—Nausea—Conjugated Estrogens—prostate cancer	9.19e-05	0.00127	CcSEcCtD
Isoniazid—Anorexia—Etoposide—prostate cancer	9.15e-05	0.00127	CcSEcCtD
Isoniazid—Hypersensitivity—Estradiol—prostate cancer	9.13e-05	0.00126	CcSEcCtD
Isoniazid—Body temperature increased—Mitoxantrone—prostate cancer	9.12e-05	0.00126	CcSEcCtD
Isoniazid—Asthenia—Estradiol—prostate cancer	8.89e-05	0.00123	CcSEcCtD
Isoniazid—Ill-defined disorder—Capecitabine—prostate cancer	8.78e-05	0.00122	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—prostate cancer	8.67e-05	0.0012	CcSEcCtD
Isoniazid—Paraesthesia—Etoposide—prostate cancer	8.62e-05	0.00119	CcSEcCtD
Isoniazid—Hyperglycaemia—Epirubicin—prostate cancer	8.54e-05	0.00118	CcSEcCtD
Isoniazid—Malaise—Capecitabine—prostate cancer	8.54e-05	0.00118	CcSEcCtD
Isoniazid—Hypersensitivity—Mitoxantrone—prostate cancer	8.5e-05	0.00118	CcSEcCtD
Isoniazid—Convulsion—Docetaxel—prostate cancer	8.47e-05	0.00117	CcSEcCtD
Isoniazid—Decreased appetite—Etoposide—prostate cancer	8.35e-05	0.00115	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Etoposide—prostate cancer	8.29e-05	0.00115	CcSEcCtD
Isoniazid—Asthenia—Mitoxantrone—prostate cancer	8.28e-05	0.00115	CcSEcCtD
Isoniazid—Fatigue—Etoposide—prostate cancer	8.28e-05	0.00115	CcSEcCtD
Isoniazid—Neuropathy peripheral—Epirubicin—prostate cancer	8.27e-05	0.00114	CcSEcCtD
Isoniazid—Jaundice—Epirubicin—prostate cancer	8.22e-05	0.00114	CcSEcCtD
Isoniazid—Discomfort—Capecitabine—prostate cancer	7.96e-05	0.0011	CcSEcCtD
Isoniazid—Feeling abnormal—Etoposide—prostate cancer	7.91e-05	0.00109	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—prostate cancer	7.9e-05	0.00109	CcSEcCtD
Isoniazid—Vomiting—Estradiol—prostate cancer	7.88e-05	0.00109	CcSEcCtD
Isoniazid—Agranulocytosis—Epirubicin—prostate cancer	7.87e-05	0.00109	CcSEcCtD
Isoniazid—Ill-defined disorder—Prednisone—prostate cancer	7.82e-05	0.00108	CcSEcCtD
Isoniazid—Thrombocytopenia—Docetaxel—prostate cancer	7.81e-05	0.00108	CcSEcCtD
Isoniazid—Rash—Estradiol—prostate cancer	7.81e-05	0.00108	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—prostate cancer	7.65e-05	0.00106	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—prostate cancer	7.61e-05	0.00105	CcSEcCtD
Isoniazid—Anorexia—Docetaxel—prostate cancer	7.61e-05	0.00105	CcSEcCtD
Isoniazid—Malaise—Prednisone—prostate cancer	7.6e-05	0.00105	CcSEcCtD
Isoniazid—Body temperature increased—Etoposide—prostate cancer	7.59e-05	0.00105	CcSEcCtD
Isoniazid—Hepatitis—Epirubicin—prostate cancer	7.57e-05	0.00105	CcSEcCtD
Isoniazid—Thrombocytopenia—Capecitabine—prostate cancer	7.56e-05	0.00105	CcSEcCtD
Isoniazid—Anorexia—Capecitabine—prostate cancer	7.36e-05	0.00102	CcSEcCtD
Isoniazid—Nausea—Estradiol—prostate cancer	7.36e-05	0.00102	CcSEcCtD
Isoniazid—Vomiting—Mitoxantrone—prostate cancer	7.34e-05	0.00102	CcSEcCtD
Isoniazid—Convulsion—Prednisone—prostate cancer	7.3e-05	0.00101	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—prostate cancer	7.29e-05	0.00101	CcSEcCtD
Isoniazid—Rash—Mitoxantrone—prostate cancer	7.28e-05	0.00101	CcSEcCtD
Isoniazid—Paraesthesia—Docetaxel—prostate cancer	7.16e-05	0.000991	CcSEcCtD
Isoniazid—Discomfort—Prednisone—prostate cancer	7.09e-05	0.000981	CcSEcCtD
Isoniazid—Hypersensitivity—Etoposide—prostate cancer	7.07e-05	0.000979	CcSEcCtD
Isoniazid—Dyspepsia—Docetaxel—prostate cancer	7.02e-05	0.000972	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—prostate cancer	7.01e-05	0.00097	CcSEcCtD
Isoniazid—Paraesthesia—Capecitabine—prostate cancer	6.94e-05	0.00096	CcSEcCtD
Isoniazid—Decreased appetite—Docetaxel—prostate cancer	6.94e-05	0.00096	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Docetaxel—prostate cancer	6.89e-05	0.000953	CcSEcCtD
Isoniazid—Asthenia—Etoposide—prostate cancer	6.89e-05	0.000953	CcSEcCtD
Isoniazid—Fatigue—Docetaxel—prostate cancer	6.88e-05	0.000952	CcSEcCtD
Isoniazid—Nausea—Mitoxantrone—prostate cancer	6.86e-05	0.000949	CcSEcCtD
Isoniazid—Dyspepsia—Capecitabine—prostate cancer	6.8e-05	0.000941	CcSEcCtD
Isoniazid—Decreased appetite—Capecitabine—prostate cancer	6.71e-05	0.000929	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Capecitabine—prostate cancer	6.67e-05	0.000923	CcSEcCtD
Isoniazid—Fatigue—Capecitabine—prostate cancer	6.66e-05	0.000921	CcSEcCtD
Isoniazid—Feeling abnormal—Docetaxel—prostate cancer	6.57e-05	0.00091	CcSEcCtD
Isoniazid—Anorexia—Prednisone—prostate cancer	6.56e-05	0.000907	CcSEcCtD
Isoniazid—Feeling abnormal—Capecitabine—prostate cancer	6.37e-05	0.000881	CcSEcCtD
Isoniazid—Body temperature increased—Docetaxel—prostate cancer	6.31e-05	0.000873	CcSEcCtD
Isoniazid—Paraesthesia—Prednisone—prostate cancer	6.18e-05	0.000855	CcSEcCtD
Isoniazid—Ill-defined disorder—Epirubicin—prostate cancer	6.12e-05	0.000846	CcSEcCtD
Isoniazid—Body temperature increased—Capecitabine—prostate cancer	6.11e-05	0.000845	CcSEcCtD
Isoniazid—Vomiting—Etoposide—prostate cancer	6.1e-05	0.000845	CcSEcCtD
Isoniazid—Dyspepsia—Prednisone—prostate cancer	6.06e-05	0.000838	CcSEcCtD
Isoniazid—Rash—Etoposide—prostate cancer	6.05e-05	0.000838	CcSEcCtD
Isoniazid—Decreased appetite—Prednisone—prostate cancer	5.98e-05	0.000828	CcSEcCtD
Isoniazid—Malaise—Epirubicin—prostate cancer	5.95e-05	0.000823	CcSEcCtD
Isoniazid—Fatigue—Prednisone—prostate cancer	5.93e-05	0.000821	CcSEcCtD
Isoniazid—Hypersensitivity—Docetaxel—prostate cancer	5.88e-05	0.000813	CcSEcCtD
Isoniazid—Asthenia—Docetaxel—prostate cancer	5.72e-05	0.000792	CcSEcCtD
Isoniazid—Convulsion—Epirubicin—prostate cancer	5.71e-05	0.00079	CcSEcCtD
Isoniazid—Nausea—Etoposide—prostate cancer	5.7e-05	0.000789	CcSEcCtD
Isoniazid—Hypersensitivity—Capecitabine—prostate cancer	5.69e-05	0.000787	CcSEcCtD
Isoniazid—Feeling abnormal—Prednisone—prostate cancer	5.67e-05	0.000785	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—prostate cancer	5.66e-05	0.000783	CcSEcCtD
Isoniazid—Discomfort—Epirubicin—prostate cancer	5.55e-05	0.000767	CcSEcCtD
Isoniazid—Asthenia—Capecitabine—prostate cancer	5.54e-05	0.000767	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—prostate cancer	5.5e-05	0.000761	CcSEcCtD
Isoniazid—Body temperature increased—Prednisone—prostate cancer	5.44e-05	0.000753	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—prostate cancer	5.29e-05	0.000731	CcSEcCtD
Isoniazid—Thrombocytopenia—Epirubicin—prostate cancer	5.27e-05	0.000729	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—prostate cancer	5.13e-05	0.00071	CcSEcCtD
Isoniazid—Anorexia—Epirubicin—prostate cancer	5.13e-05	0.00071	CcSEcCtD
Isoniazid—Vomiting—Docetaxel—prostate cancer	5.07e-05	0.000702	CcSEcCtD
Isoniazid—Hypersensitivity—Prednisone—prostate cancer	5.07e-05	0.000701	CcSEcCtD
Isoniazid—Rash—Docetaxel—prostate cancer	5.03e-05	0.000696	CcSEcCtD
Isoniazid—Asthenia—Prednisone—prostate cancer	4.94e-05	0.000683	CcSEcCtD
Isoniazid—Vomiting—Capecitabine—prostate cancer	4.91e-05	0.00068	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—prostate cancer	4.88e-05	0.000675	CcSEcCtD
Isoniazid—Rash—Capecitabine—prostate cancer	4.87e-05	0.000674	CcSEcCtD
Isoniazid—Paraesthesia—Epirubicin—prostate cancer	4.83e-05	0.000669	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—prostate cancer	4.75e-05	0.000657	CcSEcCtD
Isoniazid—Nausea—Docetaxel—prostate cancer	4.74e-05	0.000656	CcSEcCtD
Isoniazid—Dyspepsia—Epirubicin—prostate cancer	4.74e-05	0.000655	CcSEcCtD
Isoniazid—Decreased appetite—Epirubicin—prostate cancer	4.68e-05	0.000647	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Epirubicin—prostate cancer	4.65e-05	0.000643	CcSEcCtD
Isoniazid—Fatigue—Epirubicin—prostate cancer	4.64e-05	0.000642	CcSEcCtD
Isoniazid—Nausea—Capecitabine—prostate cancer	4.59e-05	0.000635	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—prostate cancer	4.47e-05	0.000619	CcSEcCtD
Isoniazid—Feeling abnormal—Epirubicin—prostate cancer	4.43e-05	0.000614	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—prostate cancer	4.38e-05	0.000606	CcSEcCtD
Isoniazid—Vomiting—Prednisone—prostate cancer	4.37e-05	0.000605	CcSEcCtD
Isoniazid—Rash—Prednisone—prostate cancer	4.34e-05	0.0006	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—prostate cancer	4.33e-05	0.000599	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.3e-05	0.000595	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—prostate cancer	4.29e-05	0.000594	CcSEcCtD
Isoniazid—Body temperature increased—Epirubicin—prostate cancer	4.25e-05	0.000589	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—prostate cancer	4.1e-05	0.000568	CcSEcCtD
Isoniazid—Nausea—Prednisone—prostate cancer	4.09e-05	0.000565	CcSEcCtD
Isoniazid—Hypersensitivity—Epirubicin—prostate cancer	3.96e-05	0.000549	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—prostate cancer	3.94e-05	0.000545	CcSEcCtD
Isoniazid—Asthenia—Epirubicin—prostate cancer	3.86e-05	0.000534	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—prostate cancer	3.67e-05	0.000508	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—prostate cancer	3.57e-05	0.000494	CcSEcCtD
Isoniazid—Vomiting—Epirubicin—prostate cancer	3.42e-05	0.000473	CcSEcCtD
Isoniazid—Rash—Epirubicin—prostate cancer	3.39e-05	0.000469	CcSEcCtD
Isoniazid—Nausea—Epirubicin—prostate cancer	3.2e-05	0.000442	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—prostate cancer	3.17e-05	0.000438	CcSEcCtD
Isoniazid—Rash—Doxorubicin—prostate cancer	3.14e-05	0.000434	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—prostate cancer	2.96e-05	0.000409	CcSEcCtD
Isoniazid—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.16e-06	2.24e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.14e-06	2.23e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.13e-06	2.22e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.12e-06	2.21e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTA1—prostate cancer	2.12e-06	2.21e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP1A1—prostate cancer	2.12e-06	2.2e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—COMT—prostate cancer	2.11e-06	2.2e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ACHE—prostate cancer	2.11e-06	2.19e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTT1—prostate cancer	2.11e-06	2.19e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTP1—prostate cancer	2.1e-06	2.19e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ERCC2—prostate cancer	2.1e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CG—prostate cancer	2.1e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.1e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTO1—prostate cancer	2.1e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NAT2—prostate cancer	2.1e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.09e-06	2.18e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GGT1—prostate cancer	2.09e-06	2.17e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.08e-06	2.17e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.08e-06	2.16e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.07e-06	2.16e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NQO1—prostate cancer	2.07e-06	2.15e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ITPR1—prostate cancer	2.07e-06	2.15e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NCOA1—prostate cancer	2.06e-06	2.14e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NQO1—prostate cancer	2.05e-06	2.13e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—TH—prostate cancer	2.04e-06	2.12e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.03e-06	2.11e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—TH—prostate cancer	2.02e-06	2.1e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.02e-06	2.1e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PRKACB—prostate cancer	2.02e-06	2.1e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PLCB2—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—LRP2—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.01e-06	2.09e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP3A4—prostate cancer	2e-06	2.08e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP17A1—prostate cancer	2e-06	2.08e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.99e-06	2.07e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—INS—prostate cancer	1.99e-06	2.07e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.98e-06	2.06e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—MTHFR—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—P4HB—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.97e-06	2.05e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP1B1—prostate cancer	1.97e-06	2.04e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—RXRA—prostate cancer	1.96e-06	2.03e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—TYMS—prostate cancer	1.95e-06	2.03e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CREBBP—prostate cancer	1.95e-06	2.02e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PPARA—prostate cancer	1.94e-06	2.01e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTM1—prostate cancer	1.93e-06	2.01e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GGT1—prostate cancer	1.92e-06	2e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.92e-06	2e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GGT1—prostate cancer	1.9e-06	1.98e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.9e-06	1.98e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOA2—prostate cancer	1.9e-06	1.98e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—LPL—prostate cancer	1.9e-06	1.97e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NCOA1—prostate cancer	1.89e-06	1.97e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—COMT—prostate cancer	1.89e-06	1.96e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTP1—prostate cancer	1.88e-06	1.95e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NCOA1—prostate cancer	1.88e-06	1.95e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.87e-06	1.95e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.86e-06	1.94e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP19A1—prostate cancer	1.85e-06	1.92e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ITPR1—prostate cancer	1.85e-06	1.92e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CD—prostate cancer	1.85e-06	1.92e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MED12—prostate cancer	1.84e-06	1.91e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP1A1—prostate cancer	1.83e-06	1.9e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GNG5—prostate cancer	1.83e-06	1.9e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CAV1—prostate cancer	1.82e-06	1.89e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ERCC2—prostate cancer	1.82e-06	1.89e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.82e-06	1.89e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC5A5—prostate cancer	1.81e-06	1.89e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—RXRA—prostate cancer	1.8e-06	1.87e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—RXRA—prostate cancer	1.78e-06	1.85e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP2E1—prostate cancer	1.77e-06	1.84e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA3—prostate cancer	1.76e-06	1.83e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NQO1—prostate cancer	1.75e-06	1.82e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—TYMS—prostate cancer	1.74e-06	1.81e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—NOS3—prostate cancer	1.74e-06	1.81e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.74e-06	1.8e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—COMT—prostate cancer	1.73e-06	1.8e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—TH—prostate cancer	1.73e-06	1.8e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTP1—prostate cancer	1.73e-06	1.79e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTM1—prostate cancer	1.72e-06	1.79e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—COMT—prostate cancer	1.72e-06	1.79e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.72e-06	1.78e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTP1—prostate cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP3A4—prostate cancer	1.71e-06	1.78e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—MTHFR—prostate cancer	1.71e-06	1.77e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.7e-06	1.77e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ITPR1—prostate cancer	1.7e-06	1.77e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—LPL—prostate cancer	1.69e-06	1.76e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ITPR1—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP1B1—prostate cancer	1.68e-06	1.75e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—HPGDS—prostate cancer	1.68e-06	1.74e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PPARA—prostate cancer	1.67e-06	1.74e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.67e-06	1.73e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.66e-06	1.73e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.66e-06	1.72e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP1A1—prostate cancer	1.63e-06	1.7e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ACHE—prostate cancer	1.63e-06	1.69e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTT1—prostate cancer	1.63e-06	1.69e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GGT1—prostate cancer	1.63e-06	1.69e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ERCC2—prostate cancer	1.62e-06	1.69e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.61e-06	1.67e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CB—prostate cancer	1.61e-06	1.67e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—TYMS—prostate cancer	1.6e-06	1.67e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NCOA1—prostate cancer	1.6e-06	1.67e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTGS2—prostate cancer	1.59e-06	1.66e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—TYMS—prostate cancer	1.59e-06	1.65e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTM1—prostate cancer	1.59e-06	1.65e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.58e-06	1.64e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CAV1—prostate cancer	1.57e-06	1.64e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTM1—prostate cancer	1.57e-06	1.63e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—INS—prostate cancer	1.57e-06	1.63e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.57e-06	1.63e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PRKACB—prostate cancer	1.56e-06	1.62e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—LPL—prostate cancer	1.56e-06	1.62e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—LPL—prostate cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CREBBP—prostate cancer	1.54e-06	1.6e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—RXRA—prostate cancer	1.52e-06	1.59e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—MTHFR—prostate cancer	1.52e-06	1.58e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.5e-06	1.56e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.5e-06	1.56e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PPARA—prostate cancer	1.49e-06	1.55e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ERCC2—prostate cancer	1.49e-06	1.55e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP1A1—prostate cancer	1.49e-06	1.55e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.48e-06	1.54e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ERCC2—prostate cancer	1.48e-06	1.54e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—COMT—prostate cancer	1.47e-06	1.53e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA2—prostate cancer	1.47e-06	1.53e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTP1—prostate cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.46e-06	1.52e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ITPR1—prostate cancer	1.44e-06	1.5e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CG—prostate cancer	1.43e-06	1.49e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.41e-06	1.47e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CAV1—prostate cancer	1.41e-06	1.46e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—MTHFR—prostate cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.4e-06	1.46e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTEN—prostate cancer	1.39e-06	1.45e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—MTHFR—prostate cancer	1.39e-06	1.44e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—NOS3—prostate cancer	1.38e-06	1.43e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PPARA—prostate cancer	1.37e-06	1.43e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.37e-06	1.42e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PPARA—prostate cancer	1.36e-06	1.42e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—TYMS—prostate cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—INS—prostate cancer	1.36e-06	1.41e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NQO1—prostate cancer	1.35e-06	1.41e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTM1—prostate cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.34e-06	1.4e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—TH—prostate cancer	1.33e-06	1.39e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CREBBP—prostate cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—EP300—prostate cancer	1.33e-06	1.38e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—LPL—prostate cancer	1.32e-06	1.37e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.3e-06	1.35e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CAV1—prostate cancer	1.29e-06	1.34e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CAV1—prostate cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.28e-06	1.33e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.27e-06	1.32e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ERCC2—prostate cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CD—prostate cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTGS2—prostate cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GGT1—prostate cancer	1.26e-06	1.31e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NCOA1—prostate cancer	1.24e-06	1.29e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.22e-06	1.27e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—INS—prostate cancer	1.21e-06	1.26e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—NOS3—prostate cancer	1.19e-06	1.24e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—MTHFR—prostate cancer	1.19e-06	1.23e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CREBBP—prostate cancer	1.19e-06	1.23e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—RXRA—prostate cancer	1.18e-06	1.22e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.17e-06	1.21e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PPARA—prostate cancer	1.16e-06	1.21e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—COMT—prostate cancer	1.13e-06	1.18e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTP1—prostate cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.13e-06	1.17e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—INS—prostate cancer	1.11e-06	1.16e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ITPR1—prostate cancer	1.11e-06	1.15e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—INS—prostate cancer	1.1e-06	1.15e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CB—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTEN—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CAV1—prostate cancer	1.1e-06	1.14e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CREBBP—prostate cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTGS2—prostate cancer	1.09e-06	1.13e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CREBBP—prostate cancer	1.08e-06	1.13e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—NOS3—prostate cancer	1.06e-06	1.1e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—TYMS—prostate cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—EP300—prostate cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.05e-06	1.09e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTM1—prostate cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.04e-06	1.08e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.03e-06	1.07e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—LPL—prostate cancer	1.02e-06	1.06e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CG—prostate cancer	9.97e-07	1.04e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.83e-07	1.02e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.81e-07	1.02e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CA—prostate cancer	9.81e-07	1.02e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—NOS3—prostate cancer	9.77e-07	1.02e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ERCC2—prostate cancer	9.75e-07	1.01e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTGS2—prostate cancer	9.72e-07	1.01e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—NOS3—prostate cancer	9.69e-07	1.01e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTEN—prostate cancer	9.5e-07	9.87e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—INS—prostate cancer	9.44e-07	9.82e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CREBBP—prostate cancer	9.25e-07	9.61e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—MTHFR—prostate cancer	9.16e-07	9.53e-06	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—EP300—prostate cancer	9.06e-07	9.42e-06	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CB—prostate cancer	9.02e-07	9.38e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PPARA—prostate cancer	8.99e-07	9.35e-06	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CB—prostate cancer	8.94e-07	9.3e-06	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTGS2—prostate cancer	8.94e-07	9.29e-06	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTGS2—prostate cancer	8.86e-07	9.21e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CD—prostate cancer	8.77e-07	9.12e-06	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTEN—prostate cancer	8.48e-07	8.81e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CAV1—prostate cancer	8.45e-07	8.79e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—NOS3—prostate cancer	8.28e-07	8.61e-06	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—EP300—prostate cancer	8.08e-07	8.4e-06	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—AKT1—prostate cancer	8.01e-07	8.33e-06	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTEN—prostate cancer	7.8e-07	8.11e-06	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CA—prostate cancer	7.75e-07	8.06e-06	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTEN—prostate cancer	7.73e-07	8.03e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.7e-07	8e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CB—prostate cancer	7.64e-07	7.95e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS2—prostate cancer	7.57e-07	7.87e-06	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—EP300—prostate cancer	7.44e-07	7.73e-06	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—EP300—prostate cancer	7.37e-07	7.66e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—INS—prostate cancer	7.29e-07	7.58e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CREBBP—prostate cancer	7.14e-07	7.42e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.77e-07	7.04e-06	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CA—prostate cancer	6.7e-07	6.96e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTEN—prostate cancer	6.6e-07	6.87e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—NOS3—prostate cancer	6.39e-07	6.64e-06	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—AKT1—prostate cancer	6.33e-07	6.58e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—EP300—prostate cancer	6.3e-07	6.55e-06	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CA—prostate cancer	5.98e-07	6.22e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.9e-07	6.13e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS2—prostate cancer	5.84e-07	6.08e-06	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.5e-07	5.72e-06	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—AKT1—prostate cancer	5.47e-07	5.69e-06	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CA—prostate cancer	5.45e-07	5.67e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTEN—prostate cancer	5.1e-07	5.3e-06	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—AKT1—prostate cancer	4.88e-07	5.08e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—EP300—prostate cancer	4.86e-07	5.05e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.66e-07	4.84e-06	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—AKT1—prostate cancer	4.49e-07	4.67e-06	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—AKT1—prostate cancer	4.45e-07	4.63e-06	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—AKT1—prostate cancer	3.81e-07	3.96e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.6e-07	3.74e-06	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—AKT1—prostate cancer	2.94e-07	3.05e-06	CbGpPWpGaD
